1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases
Keywords: Alzheimer's disease; Anellated xanthines; Tetrahydropyrimido[2,1-f]purinediones; Adenosine A1 receptor antagonists; Adenosine A2A receptor antagonists; Caffeine derivatives; Monoamine oxidase B inhibitors; Parkinson's disease; Tricyclic compounds; Syn